{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:32:37Z","timestamp":1773509557573,"version":"3.50.1"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Brain Res"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00221-025-07072-1","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T10:02:31Z","timestamp":1745661751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Unraveling the role of brain renin angiotensin system in vascular dementia: mechanisms and therapeutic perspectives"],"prefix":"10.1007","volume":"243","author":[{"given":"Kuldeep","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonal","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayush","family":"Kandpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramanpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amteshwar S.","family":"Jaggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harlokesh Narayan","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimple","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"issue":"3","key":"7072_CR1","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.sjbs.2020.01.026","volume":"27","author":"OA Abiodun","year":"2020","unstructured":"Abiodun OA, Ola MS (2020) Role of brain renin angiotensin system in neurodegeneration: an update. Saudi J Biol Sci 27(3):905\u2013912. https:\/\/doi.org\/10.1016\/j.sjbs.2020.01.026","journal-title":"Saudi J Biol Sci"},{"key":"7072_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1262-x","volume":"15","author":"HA Ahmed","year":"2018","unstructured":"Ahmed HA, Ishrat T, Pillai B, Fouda AY, Sayed MA, Eldahshan W, Waller JL, Ergul A, Fagan SC (2018) RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial. J Neuroinflamm 15:1\u20136. https:\/\/doi.org\/10.1186\/s12974-018-1262-x","journal-title":"J Neuroinflamm"},{"issue":"6","key":"7072_CR203","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1161\/HYPERTENSIONAHA.123.21070","volume":"80","author":"F Althammer","year":"2023","unstructured":"Althammer F, Roy RK, Kirchner MK, Campos-Lira E, Whitley KE, Davis S, Montanez J, Ferreira-Neto HC, Danh J, Feresin R, Biancardi VC, Zafar U, Parent MB, Stern JE (2023)\nAngiotensin II-Mediated neuroinflammation in the hippocampus contributes to neuronal deficits and cognitive impairment in heart failure rats. Hypertension 80(6):1258\u20131273. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.21070","journal-title":"Hypertension"},{"issue":"720715","key":"7072_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2021.720715","volume":"13","author":"F Akhter","year":"2021","unstructured":"Akhter F, Persaud A, Zaokari Y, Zhao Z, Zhu D (2021) Vascular dementia and underlying sex differences. Front Aging Neurosci 13(720715):1\u201317. https:\/\/doi.org\/10.3389\/fnagi.2021.720715","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"7072_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/syn.21588","volume":"66","author":"F Alc\u00e1ntara-Gonz\u00e1lez","year":"2012","unstructured":"Alc\u00e1ntara-Gonz\u00e1lez F, Mendoza-Perez CR, Zaragoza N, Juarez I, Arroyo-Garc\u00eda LE, Gamboa C, De La Cruz F, Zamudio S, Garcia-Dolores F, Flores G (2012) Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice. Synapse 66(11):938\u2013949. https:\/\/doi.org\/10.1002\/syn.21588","journal-title":"Synapse"},{"issue":"2","key":"7072_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1124\/jpet.112.197483","volume":"344","author":"A Alhusban","year":"2013","unstructured":"Alhusban A, Kozak A, Ergul A, Fagan SC (2013) AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. J Pharmacol Exp Ther 344(2):348\u2013359. https:\/\/doi.org\/10.1124\/jpet.112.197483","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"7072_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00004850-200309000-00003","volume":"18","author":"XA \u00c1lvarez","year":"2003","unstructured":"\u00c1lvarez XA, Sampedro C, P\u00e9rez P, Laredo M, Couceiro V, Hern\u00e1ndez \u00c1, Figueroa J, Varela M, Arias D, Corzo L, Zas R (2003) Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study. Int Clin Psychopharmacol 18(5):271\u2013278. https:\/\/doi.org\/10.1097\/00004850-200309000-00003","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"7072_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1468-1331.2006.01222.x","volume":"13","author":"XA Alvarez","year":"2006","unstructured":"Alvarez XA, Cacabelos R, Laredo M, Couceiro V, Sampedro C, Varela M, Corzo L, Fernandez-Novoa L, Vargas M, Aleixandre M, Linares C (2006) A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer\u2019s disease. Eur J Neurol 13(1):43\u201354. https:\/\/doi.org\/10.1111\/j.1468-1331.2006.01222.x","journal-title":"Eur J Neurol"},{"issue":"14","key":"7072_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1042\/CS20160382","volume":"131","author":"JP Appleton","year":"2017","unstructured":"Appleton JP, Scutt P, Sprigg N, Bath PM (2017) Hypercholesterolaemia and vascular dementia. Clin Sci 131(14):1561\u20131578. https:\/\/doi.org\/10.1042\/CS20160382","journal-title":"Clin Sci"},{"issue":"5","key":"7072_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1212\/01.wnl.0000266625.31615.f6","volume":"69","author":"AP Auchus","year":"2007","unstructured":"Auchus AP, Brashear HR, Salloway S, Korczyn AD, De Deyn PP, Gassmann-Mayer CG (2007) Galantamine treatment of vascular dementia: a randomized trial. Neurology 69(5):448\u2013458. https:\/\/doi.org\/10.1212\/01.wnl.0000266625.31615.f6","journal-title":"Neurology"},{"issue":"6","key":"7072_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.002","volume":"21","author":"K Bettermann","year":"2012","unstructured":"Bettermann K, Arnold AM, Williamson J, Rapp S, Sink K, Toole JF, Carlson MC, Yasar S, DeKosky S, Burke GL (2012) Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study. J Stroke Cerebrovasc Dis 21(6):436\u2013444. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2010.11.002","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"7072_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1139\/cjpp-2023-0226","volume":"102","author":"SK Bhullar","year":"2023","unstructured":"Bhullar SK, Dhalla NS (2023) Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure. Can J Physiol Pharmacol 102(2):86\u2013104. https:\/\/doi.org\/10.1139\/cjpp-2023-0226","journal-title":"Can J Physiol Pharmacol"},{"key":"7072_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004746.pub2","author":"J Birks","year":"2006","unstructured":"Birks J, Craig D (2006) Galantamine for vascular cognitive impairment. Cochrane Database of Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD004746.pub2","journal-title":"Cochrane Database of Syst Rev"},{"issue":"10","key":"7072_CR13","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1161\/01.STR.0000091396.95360.E1","volume":"34","author":"S Black","year":"2003","unstructured":"Black S, Rom\u00e1n GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, Kumar D, Pratt R (2003) Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 34(10):2323\u20132330. https:\/\/doi.org\/10.1161\/01.STR.0000091396.95360.E1","journal-title":"Stroke"},{"key":"7072_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s001090050360","volume":"77","author":"A Blume","year":"1999","unstructured":"Blume A, Herdegen T, Unger T (1999) Angiotensin peptides and inducible transcription factors. J Mol Med 77:339\u2013357. https:\/\/doi.org\/10.1007\/s001090050360","journal-title":"J Mol Med"},{"issue":"S1","key":"7072_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1017\/S1041610203009189","volume":"15","author":"HR Brashear","year":"2003","unstructured":"Brashear HR (2003) Galantamine in the treatment of vascular dementia. Int Psychogeriatr 15(S1):187\u2013193. https:\/\/doi.org\/10.1017\/S1041610203009189","journal-title":"Int Psychogeriatr"},{"key":"7072_CR16","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1007\/s11064-008-9775-9","volume":"33","author":"V Calabrese","year":"2008","unstructured":"Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E (2008) Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 33:2444\u20132471. https:\/\/doi.org\/10.1007\/s11064-008-9775-9","journal-title":"Neurochem Res"},{"key":"7072_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11064-007-9453-3","volume":"33","author":"A Casado","year":"2008","unstructured":"Casado A, Encarnaci\u00f3n L\u00f3pez-Fern\u00e1ndez M, Concepci\u00f3n Casado M, de La Torre R (2008) Lipid peroxidation and anti-oxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 33:450\u2013458. https:\/\/doi.org\/10.1007\/s11064-007-9453-3","journal-title":"Neurochem Res"},{"issue":"2","key":"7072_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/HYPERTENSIONAHA.109.145409","volume":"55","author":"W Chai","year":"2010","unstructured":"Chai W, Wang W, Liu J, Barrett EJ, Carey RM, Cao W, Liu Z (2010) Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use. Hypertension 55(2):523\u2013530. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.145409","journal-title":"Hypertension"},{"issue":"101838","key":"7072_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2022.101838","volume":"85","author":"P Chakraborty","year":"2023","unstructured":"Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A, Kumar D, Ambasta RK, Jha NK, Jha SK, Dewanjee S (2023) Glutamatergic neurotransmission: a potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev 85(101838):1\u201324. https:\/\/doi.org\/10.1016\/j.arr.2022.101838","journal-title":"Ageing Res Rev"},{"key":"7072_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-5-26","volume":"5","author":"KA Chan","year":"2005","unstructured":"Chan KA, Tang NL, Hui DS, Chung GT, Wu AK, Chim SS, Chiu RW, Lee N, Choi KW, Sung YM, Chan PK (2005) Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study. BMC Infect Dis 5:1\u20136. https:\/\/doi.org\/10.1186\/1471-2334-5-26","journal-title":"BMC Infect Dis"},{"issue":"6","key":"7072_CR21","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/jch.12795","volume":"18","author":"M Chaumont","year":"2016","unstructured":"Chaumont M, Pourcelet A, Van Nuffelen M, Racap\u00e9 J, Leeman M, Hougardy JM (2016) Acute kidney injury in elderly patients with chronic kidney disease: Do angiotensin-converting enzyme inhibitors carry a risk? J Clin Hypertense 18(6):514\u2013521. https:\/\/doi.org\/10.1111\/jch.12795","journal-title":"J Clin Hypertense"},{"issue":"6","key":"7072_CR22","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3109\/02688697.2013.793287","volume":"27","author":"CC Chen","year":"2013","unstructured":"Chen CC, Wei ST, Tsaia SC, Chen XX, Cho DY (2013) Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study. Br J Neurosurg 27(6):803\u2013807. https:\/\/doi.org\/10.3109\/02688697.2013.793287","journal-title":"Br J Neurosurg"},{"issue":"3\u20134","key":"7072_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000444253","volume":"75","author":"YD Chen","year":"2016","unstructured":"Chen YD, Zhang J, Wang Y, Yuan JL, Hu WL (2016) Efficacy of cholinesterase inhibitors in vascular dementia: an updated meta-analysis. Eur Neurol 75(3\u20134):132\u2013141. https:\/\/doi.org\/10.1159\/000444253","journal-title":"Eur Neurol"},{"key":"7072_CR24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ptr.8406","volume":"39","author":"S Chib","year":"2025","unstructured":"Chib S, Dutta BJ, Chalotra R, Abubakar M, Kumar P, Singh TG, Singh R (2025a) Role of flavonoids in mitigating the pathological complexities and treatment hurdles in Alzheimer\u2019s Disease. Phytother Res 39:747\u2013775. https:\/\/doi.org\/10.1002\/ptr.8406","journal-title":"Phytother Res"},{"key":"7072_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahr.2025.100223","volume":"100223","author":"S Chib","year":"2025","unstructured":"Chib S, Sharma K, Singh R (2025b) Interventions of cognitive impairment in older adults: a comprehensive review. Aging Health Res 100223:1\u20138. https:\/\/doi.org\/10.1016\/j.ahr.2025.100223","journal-title":"Aging Health Res"},{"issue":"545450","key":"7072_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2020.545450","volume":"11","author":"HI Choi","year":"2020","unstructured":"Choi HI, Ryu CW, Kim S, Rhee HY, Jahng GH (2020) Changes in microvascular morphology in subcortical vascular dementia: a study of vessel size magnetic resonance imaging. Front Neurol 11(545450):1\u20139. https:\/\/doi.org\/10.3389\/fneur.2020.545450","journal-title":"Front Neurol"},{"key":"7072_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008900.pub3","author":"S Cui","year":"2019","unstructured":"Cui S, Chen N, Yang M, Guo J, Zhou M, Zhu C, He L (2019) Cerebrolysin for vascular dementia. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008900.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"2\u20133","key":"7072_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/rej.2009.0944","volume":"13","author":"L Danielyan","year":"2010","unstructured":"Danielyan L, Klein R, Hanson LR, Buadze M, Schwab M, Gleiter CH, Frey WH (2010) Protective effects of intranasal losartan in the APP\/PS1 transgenic mouse model of Alzheimer disease. Rejuvenation Res 13(2\u20133):195\u2013201. https:\/\/doi.org\/10.1089\/rej.2009.0944","journal-title":"Rejuvenation Res"},{"issue":"2","key":"7072_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.5606\/jebms.2022.1018","volume":"3","author":"D Da\u015fdelen","year":"2022","unstructured":"Da\u015fdelen D, Kayaalt\u0131 A, Altunta\u015f \u0130, Erba\u015f O (2022) N-Methyl D-aspartic acid receptors: an overview. J Exp Basic Med Sci 3(2):118\u2013124. https:\/\/doi.org\/10.5606\/jebms.2022.1018","journal-title":"J Exp Basic Med Sci"},{"issue":"4","key":"7072_CR30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JAD-2011-110347","volume":"26","author":"NM Davies","year":"2011","unstructured":"Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM (2011) Associations of antihypertensive treatments with Alzheimer\u2019s disease, vascular dementia, and other dementias. J Alzheimers Dis 26(4):699\u2013708. https:\/\/doi.org\/10.3233\/JAD-2011-110347","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"7072_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/encyclopedia2010007","volume":"2","author":"L De Masi","year":"2022","unstructured":"De Masi L, Argenio MA, Giordano D, Facchiano A (2022) Molecular aspects of spike\u2013ACE2 interaction. Encyclopedia 2(1):96\u2013108. https:\/\/doi.org\/10.3390\/encyclopedia2010007","journal-title":"Encyclopedia"},{"issue":"s3","key":"7072_CR32","doi-asserted-by":"publisher","first-page":"S321","DOI":"10.3233\/JAD-132189","volume":"42","author":"FF de Oliveira","year":"2014","unstructured":"de Oliveira FF, Bertolucci PH, Chen ES, Smith MC (2014) Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change in patients with dementia due to Alzheimer\u2019s disease. J Alzheimers Dis 42(s3):S321-3244. https:\/\/doi.org\/10.3233\/JAD-132189","journal-title":"J Alzheimers Dis"},{"key":"7072_CR33","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","volume":"29","author":"R Dhapola","year":"2021","unstructured":"Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH (2021) Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease. Inflammopharmacology 29:1669\u20131681. https:\/\/doi.org\/10.1007\/s10787-021-00889-6","journal-title":"Inflammopharmacology"},{"issue":"3","key":"7072_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/CIRCRESAHA.116.308426","volume":"120","author":"M Dichgans","year":"2017","unstructured":"Dichgans M, Leys D (2017) Vascular Cognitive Impairment. Circ Res 120(3):573\u2013591. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308426","journal-title":"Circ Res"},{"issue":"8","key":"7072_CR35","first-page":"773","volume":"41","author":"K Ditzler","year":"1991","unstructured":"Ditzler K (1991) Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo-controlled trial. Arzneimittelforschung 41(8):773\u2013780","journal-title":"Arzneimittelforschung"},{"issue":"647990","key":"7072_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2021.647990","volume":"13","author":"MT Duong","year":"2021","unstructured":"Duong MT, Nasrallah IM, Wolk DA, Chang CC, Chang TY (2021) Cholesterol, atherosclerosis, and APOE in vascular contributions to cognitive impairment and dementia (VCID): potential mechanisms and therapy. Front Aging Neurosci 13(647990):1\u201312. https:\/\/doi.org\/10.3389\/fnagi.2021.647990","journal-title":"Front Aging Neurosci"},{"issue":"102125","key":"7072_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2023.102125","volume":"92","author":"BJ Dutta","year":"2023","unstructured":"Dutta BJ, Rakshe PS, Maurya N, Chib S, Singh S (2023) Unlocking the therapeutic potential of natural stilbene: exploring pterostilbene as a powerful ally against aging and cognitive decline. Ageing Res Rev 92(102125):1\u201319. https:\/\/doi.org\/10.1016\/j.arr.2023.102125","journal-title":"Ageing Res Rev"},{"key":"7072_CR38","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1007\/s12035-016-0051-8","volume":"54","author":"AM El-Dessouki","year":"2017","unstructured":"El-Dessouki AM, Galal MA, Awad AS, Zaki HF (2017) Neuroprotective effects of simvastatin and cilostazol in L-methionine-induced vascular dementia in rats. Mol Neurobiol 54:5074\u20135084. https:\/\/doi.org\/10.1007\/s12035-016-0051-8","journal-title":"Mol Neurobiol"},{"key":"7072_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12017-011-8157-7","volume":"13","author":"MW Elmlinger","year":"2011","unstructured":"Elmlinger MW, Kriebel M, Ziegler D (2011) Neuroprotective and anti-oxidative effects of the hemodialysate actovegin on primary rat neurons in vitro. Neuromol Med 13:266\u2013274. https:\/\/doi.org\/10.1007\/s12017-011-8157-7","journal-title":"Neuromol Med"},{"issue":"5","key":"7072_CR40","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2183\/pjab.86.484","volume":"86","author":"A Endo","year":"2010","unstructured":"Endo A (2010) A historical perspective on the discovery of statins. Proc Jpn Acad Ser B 86(5):484\u2013493. https:\/\/doi.org\/10.2183\/pjab.86.484","journal-title":"Proc Jpn Acad Ser B"},{"issue":"Suppl. 1","key":"7072_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000107395","volume":"24","author":"T Erkinjuntti","year":"2007","unstructured":"Erkinjuntti T (2007) Vascular cognitive deterioration and stroke. Cerebrovasc Dis 24(Suppl. 1):189\u2013194. https:\/\/doi.org\/10.1159\/000107395","journal-title":"Cerebrovasc Dis"},{"issue":"10","key":"7072_CR42","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1073\/pnas.081620098","volume":"98","author":"K Fassbender","year":"2001","unstructured":"Fassbender K, Simons M, Bergmann C, Stroick M, L\u00fctjohann D, Keller P, Runz H, K\u00fchl S, Bertsch T, Von Bergmann K, Hennerici M (2001) Simvastatin strongly reduces levels of Alzheimer\u2019s disease \u03b2-amyloid peptides A\u03b242 and A\u03b240 in vitro and in vivo. Proc Natl Acad Sci U S A 98(10):5856\u20135861. https:\/\/doi.org\/10.1073\/pnas.081620098","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7072_CR43","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s10072-021-05089-2","volume":"42","author":"B Fiani","year":"2021","unstructured":"Fiani B, Covarrubias C, Wong A, Doan T, Reardon T, Nikolaidis D, Sarno E (2021) Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes. Neurol Sci 42:1345\u20131353. https:\/\/doi.org\/10.1007\/s10072-021-05089-2","journal-title":"Neurol Sci"},{"issue":"4","key":"7072_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4088\/PCC.v10n0404","volume":"10","author":"GS Figiel","year":"2008","unstructured":"Figiel GS, Sadowsky CH, Strigas J, Koumaras B, Meng X, Gunay I (2008) Safety and efficacy of rivastigmine in patients with Alzheimer\u2019s disease not responding adequately to donepezil: an open-label study. Prim Care Companion J Clin Psychiatry 10(4):291\u2013298","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"9","key":"7072_CR45","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.3390\/ijms21093181","volume":"21","author":"FC Firan","year":"2020","unstructured":"Firan FC, Romila A, Onose G (2020) Current synthesis and systematic review of main effects of calf blood deproteinized medicine (Actovegin\u00ae) in ischemic stroke. Int J Mol Sci 21(9):3181","journal-title":"Int J Mol Sci"},{"key":"7072_CR46","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00228-003-0717-9","volume":"59","author":"R Fogari","year":"2004","unstructured":"Fogari R, Mugellini A, Zoppi A, Marasi G, Pasotti C, Poletti L, Rinaldi A, Preti P (2004) Effects of valsartan compared with Enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. Eur J Clin Pharmacol 59:863\u2013868. https:\/\/doi.org\/10.1007\/s00228-003-0717-9","journal-title":"Eur J Clin Pharmacol"},{"key":"7072_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10072-012-1174-y","volume":"34","author":"P Formichi","year":"2013","unstructured":"Formichi P, Radi E, Battisti C, Di Maio G, Dotti MT, Muresanu D, Federico A (2013) Effects of cerebrolysin administration on oxidative stress-induced apoptosis in lymphocytes from CADASIL patients. Neurol Sci 34:553\u2013556. https:\/\/doi.org\/10.1007\/s10072-012-1174-y","journal-title":"Neurol Sci"},{"issue":"4","key":"7072_CR48","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1161\/ATVBAHA.118.311906","volume":"39","author":"AY Fouda","year":"2019","unstructured":"Fouda AY, Fagan SC, Ergul A (2019) Brain vasculature and cognition: Renin-angiotensin system, endothelin, and beyond. Arterioscler Thromb Vasc Biol 39(4):593\u2013602. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311906","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"7072_CR49","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1161\/CIRCRESAHA.116.309602","volume":"119","author":"J Gallego-Delgado","year":"2016","unstructured":"Gallego-Delgado J, Walther T, Rodriguez A (2016) The high blood pressure-malaria protection hypothesis. Cir Res 119(10):1071\u20131075. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309602","journal-title":"Cir Res"},{"issue":"15","key":"7072_CR50","doi-asserted-by":"publisher","first-page":"24099","DOI":"10.18632\/oncotarget.15732","volume":"8","author":"Q Gao","year":"2017","unstructured":"Gao Q, Ou Z, Jiang T, Tian YY, Zhou JS, Wu L, Shi JQ, Zhang YD (2017) Azilsartan ameliorates apoptosis of dopaminergic neurons and rescues characteristic parkinsonian behaviors in a rat model of Parkinson\u2019s disease. Oncotarget 8(15):24099\u201324109","journal-title":"Oncotarget"},{"issue":"2","key":"7072_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.01.025","volume":"27","author":"Y Gao","year":"2018","unstructured":"Gao Y, Li W, Liu Y, Wang Y, Zhang J, Li M, Bu M (2018) Effect of telmisartan on preventing learning and memory deficits via peroxisome proliferator-activated receptor-\u03b3 in vascular dementia spontaneously hypertensive rats. J Stroke Cerebrovasc Dis 27(2):277\u2013285. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.01.025","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"7072_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.nrleng.2011.12.013","volume":"30","author":"PR Garc\u00eda","year":"2015","unstructured":"Garc\u00eda PR, Garc\u00eda DR (2015) Diagnosis of vascular cognitive impairment and its main categories. Neurolog\u00eda (English Edition) 30(4):223\u2013239. https:\/\/doi.org\/10.1016\/j.nrleng.2011.12.013","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"5","key":"7072_CR53","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/cbf.3635","volume":"39","author":"CA Garc\u00eda-Carlos","year":"2021","unstructured":"Garc\u00eda-Carlos CA, Camargo-Loaiza JA, Garc\u00eda-Villa D, L\u00f3pez-Cervantes JG, Dom\u00ednguez-Avila JA, Gonz\u00e1lez-Aguilar GA, Astiazaran-Garcia H, Montiel-Herrera M (2021) Angiotensin II, ATP and high extracellular potassium induced intracellular calcium responses in primary rat brain endothelial cell cultures. Cell Biochem Funct 39(5):688\u2013698. https:\/\/doi.org\/10.1002\/cbf.3635","journal-title":"Cell Biochem Funct"},{"issue":"5\u20136","key":"7072_CR54","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000377672","volume":"39","author":"S Gauthier","year":"2015","unstructured":"Gauthier S, Proano JV, Jia J, Froelich L, Vester JC, Doppler E (2015) Cerebrolysin in mild-to-moderate Alzheimer\u2019s disease: a meta-analysis of randomized controlled clinical trials. Dement Geriatr Cogn Disord 39(5\u20136):332\u2013347. https:\/\/doi.org\/10.1159\/000377672","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"9","key":"7072_CR55","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1210\/mend.13.9.0344","volume":"13","author":"L Gendron","year":"1999","unstructured":"Gendron L, Laflamme L, Rivard N, Asselin C, Payet MD, Gallo-Payet N (1999) Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p21ras and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108\u201315 cells. Mol Endocrinol 13(9):1615\u20131626. https:\/\/doi.org\/10.1210\/mend.13.9.0344","journal-title":"Mol Endocrinol"},{"issue":"6","key":"7072_CR56","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1074\/jbc.m202446200","volume":"278","author":"L Gendron","year":"2003","unstructured":"Gendron L, Oligny JF, Payet MD, Gallo-Payet N (2003) Cyclic AMP-independent involvement of Rap1\/B-Raf in the angiotensin II AT2 receptor signaling pathway in NG108-15 cells. J Biol Chem 278(6):3606\u20133614. https:\/\/doi.org\/10.1074\/jbc.m202446200","journal-title":"J Biol Chem"},{"issue":"1668","key":"7072_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01668","volume":"10","author":"P Gervois","year":"2019","unstructured":"Gervois P, Lambrichts I (2019) The emerging role of triggering receptor expressed on myeloid cells 2 as a target for immunomodulation in ischemic stroke. Front Immunol 10(1668):1\u20138. https:\/\/doi.org\/10.3389\/fimmu.2019.01668","journal-title":"Front Immunol"},{"issue":"3","key":"7072_CR58","first-page":"153","volume":"10","author":"K Gharagozli","year":"2017","unstructured":"Gharagozli K, Harandi AA, Houshmand S, Akbari N, Muresanu DF, Vester J, Winter S, Moessler H (2017) Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial. J Med Life 10(3):153\u2013160","journal-title":"J Med Life"},{"key":"7072_CR59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.physbeh.2018.12.012","volume":"201","author":"SS Gocmez","year":"2019","unstructured":"Gocmez SS, \u015eahin TD, Yazir Y, Duruksu G, Eraldemir FC, Polat S, Utkan T (2019) Resveratrol prevents cognitive deficits by attenuating oxidative damage and inflammation in rat model of streptozotocin diabetes induced vascular dementia. Physiol Behav 201:198\u2013207. https:\/\/doi.org\/10.1016\/j.physbeh.2018.12.012","journal-title":"Physiol Behav"},{"issue":"5","key":"7072_CR202","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bbadis.2015.12.015","volume":"1862","author":"PB Gorelick","year":"2016","unstructured":"Gorelick PB, Counts SE, Nyenhuis D (2016) Vascular cognitive impairment and dementia. Biochim Biophys Acta 1862(5):860\u2013868. https:\/\/doi.org\/10.1016\/j.bbadis.2015.12.015","journal-title":"Biochim Biophys Acta"},{"issue":"101612","key":"7072_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2022.101612","volume":"77","author":"F Gouveia","year":"2022","unstructured":"Gouveia F, Camins A, Ettcheto M, Bicker J, Falcao A, Cruz MT, Fortuna A (2022) Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer\u2019s disease: Past, present and future. Ageing Res Rev 77(101612):1\u201327. https:\/\/doi.org\/10.1016\/j.arr.2022.101612","journal-title":"Ageing Res Rev"},{"issue":"2","key":"7072_CR62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/2348-9995.195601","volume":"3","author":"S Grover","year":"2016","unstructured":"Grover S, Somani A (2016) Etiologies and risk factors for dementia. J Ger Mental Health 3(2):100\u2013107. https:\/\/doi.org\/10.4103\/2348-9995.195601","journal-title":"J Ger Mental Health"},{"issue":"4","key":"7072_CR63","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.01.012","volume":"20","author":"AB Guekht","year":"2011","unstructured":"Guekht AB, Moessler H, Novak PH, Gusev EI, Cerebrolysin Investigators (2011) Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial. J Stroke Cerebrovasc Dis 20(4):310\u2013318. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2010.01.012","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"7072_CR64","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/strokeaha.116.014321","volume":"48","author":"A Guekht","year":"2017","unstructured":"Guekht A, Skoog I, Edmundson S, Zakharov V, Korczyn AD (2017) ARTEMIDA Trial (a randomized trial of efficacy, 12 months international double-blind Actovegin) a randomized controlled trial to assess the efficacy of Actovegin in poststroke cognitive impairment. Stroke 48(5):1262\u20131270. https:\/\/doi.org\/10.1161\/strokeaha.116.014321","journal-title":"Stroke"},{"issue":"2","key":"7072_CR65","doi-asserted-by":"publisher","first-page":"116","DOI":"10.15407\/cryo31.02.116","volume":"31","author":"O Gulevsky","year":"2021","unstructured":"Gulevsky O, Moisieieva N, Gorina O, Akhatova Y (2021) Comparative Evaluation of Wound Healing Effect of Cord Blood Low Molecular Weight Fraction (Below 5 kDa) and Actovegin Drug in Skin Cryolesions. Probl Cryobiol Cryomed 31(2):116\u2013126","journal-title":"Probl Cryobiol Cryomed"},{"issue":"11","key":"7072_CR66","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.07.023","volume":"25","author":"S Gupta","year":"2016","unstructured":"Gupta S, Singh P, Sharma B (2016) Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia. J Stroke Cerebrovasc Dis 25(11):2717\u20132728. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.07.023","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10","key":"7072_CR67","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/glia.20996","volume":"58","author":"ND Halim","year":"2010","unstructured":"Halim ND, Mcfate T, Mohyeldin A, Okagaki P, Korotchkina LG, Patel MS, Jeoung NH, Harris RA, Schell MJ, Verma A (2010) Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons. Glia 58(10):1168\u20131176. https:\/\/doi.org\/10.1002\/glia.20996","journal-title":"Glia"},{"key":"7072_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-018-1995-z","volume":"22","author":"A Hall","year":"2018","unstructured":"Hall A, Busse LW, Ostermann M (2018) Angiotensin in critical care. Crit Care 22:1\u20136. https:\/\/doi.org\/10.1186\/s13054-018-1995-z","journal-title":"Crit Care"},{"key":"7072_CR69","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s007020170067","volume":"108","author":"M Hartbauer","year":"2001","unstructured":"Hartbauer M, Hutter-Paier B, Skofitsch G, Windisch M (2001) Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons. J Neural Transm 108:459\u2013473. https:\/\/doi.org\/10.1007\/s007020170067","journal-title":"J Neural Transm"},{"key":"7072_CR70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ijdevneu.2014.07.005","volume":"38","author":"K Hartwig","year":"2014","unstructured":"Hartwig K, Fackler V, Jaksch-Bogensperger H, Winter S, Furtner T, Couillard-Despres S, Meier D, Moessler H, Aigner L (2014) Cerebrolysin protects PC12 cells from CoCl2-induced hypoxia employing GSK3\u03b2 signaling. Int J Dev Neurosci 38:52\u201358. https:\/\/doi.org\/10.1016\/j.ijdevneu.2014.07.005","journal-title":"Int J Dev Neurosci"},{"key":"7072_CR71","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.bbadis.2015.12.009","volume":"5","author":"AM Helman","year":"1862","unstructured":"Helman AM, Murphy MP (2016) Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo. Biochim Biophys Acta Mol Basis Dis 5:975\u2013982. https:\/\/doi.org\/10.1016\/j.bbadis.2015.12.009","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7072_CR72","first-page":"46","volume":"5","author":"WM Herrmann","year":"1992","unstructured":"Herrmann WM, Bohn-Olszewsky WJ, Kuntz G (1992) Infusionstherapie mit Actovegin bei Patienten mit ptimar degenerativer Demenz vom Alzheimer Typ und Multiinfarkt Demenz. Z Geriatrie 5:46\u201355","journal-title":"Z Geriatrie"},{"issue":"106649","key":"7072_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2020.106649","volume":"125","author":"H Holm","year":"2020","unstructured":"Holm H, Ricci F, Di Martino G, Bachus E, Nilsson ED, Ballerini P, Melander O, Hansson O, N\u00e4gga K, Magnusson M, Fedorowski A (2020) Beta-blocker therapy and risk of vascular dementia: a population-based prospective study. Vasc Pharmacol 125(106649):1\u20137. https:\/\/doi.org\/10.1016\/j.vph.2020.106649","journal-title":"Vasc Pharmacol"},{"key":"7072_CR74","first-page":"331","volume":"7","author":"Z Hong","year":"2005","unstructured":"Hong Z, Zhu GX, Chen HB (2005) The clinical efficacy of Cerebrolysin in the treatment of acute ischemic stroke. Chin J Geriatr Heart Brain Vessel Dis 7:331\u2013333","journal-title":"Chin J Geriatr Heart Brain Vessel Dis"},{"issue":"2","key":"7072_CR77","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/hypertensionaha.108.123612","volume":"53","author":"S Inaba","year":"2009","unstructured":"Inaba S, Iwai M, Furuno M, Tomono Y, Kanno H, Senba I, Okayama H, Mogi M, Higaki J, Horiuchi M (2009) Continuous activation of renin-angiotensin system impairs cognitive function in renin\/angiotensinogen transgenic mice. Hypertension 53(2):356\u2013362. https:\/\/doi.org\/10.1161\/hypertensionaha.108.123612","journal-title":"Hypertension"},{"issue":"1","key":"7072_CR78","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-023-00640-5","volume":"18","author":"Y Inoue","year":"2023","unstructured":"Inoue Y, Shue F, Bu G, Kanekiyo T (2023) Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease. Mol Neurodegener 18(1):46","journal-title":"Mol Neurodegener"},{"issue":"2","key":"7072_CR79","first-page":"113","volume":"27","author":"F Iranmanesh","year":"2020","unstructured":"Iranmanesh F, Shafiee K, Farzan A (2020) The Effects of Donepezil, Galantamine, Rivastigmine and Memantine on Mini-Mental State Examination and Mean Flow Velocity in Patients with Vascular Dementia: A Double-Blinded Randomized Clinical Trial. J Kerman Univ Med Sci 27(2):113\u2013119","journal-title":"J Kerman Univ Med Sci"},{"key":"7072_CR80","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bbr.2018.05.023","volume":"356","author":"X Jiang","year":"2019","unstructured":"Jiang X, Niu X, Guo Q, Dong Y, Xu J, Yin N, Qi Q, Jia Y, Gao L, He Q, Lv P (2019) FoxO1-mediated autophagy plays an important role in the neuroprotective effects of hydrogen in a rat model of vascular dementia. Behav Brain Res 356:98\u2013106. https:\/\/doi.org\/10.1016\/j.bbr.2018.05.023","journal-title":"Behav Brain Res"},{"issue":"1","key":"7072_CR81","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","volume":"6","author":"JW Johnson","year":"2006","unstructured":"Johnson JW, Kotermanski SE (2006) Mechanism of action of memantine. Curr Opin Pharmacol 6(1):61\u201367. https:\/\/doi.org\/10.1016\/j.coph.2005.09.007","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"7072_CR82","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/archgenpsychiatry.2009.185","volume":"67","author":"RE Jorge","year":"2010","unstructured":"Jorge RE, Acion L, Moser D, Adams HP, Robinson RG (2010) Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatr 67(2):187\u2013196. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2009.185","journal-title":"Arch Gen Psychiatr"},{"issue":"11","key":"7072_CR83","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/syn.20950","volume":"65","author":"I Ju\u00e1rez","year":"2011","unstructured":"Ju\u00e1rez I, Gonz\u00e1lez DJ, Mena R, Flores G (2011) The chronic administration of cerebrolysin induces plastic changes in the prefrontal cortex and dentate gyrus in aged mice. Synapse 65(11):1128\u20131135. https:\/\/doi.org\/10.1002\/syn.20950","journal-title":"Synapse"},{"issue":"5","key":"7072_CR84","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1021\/acs.jmedchem.9b01780","volume":"63","author":"L Juillerat-Jeanneret","year":"2020","unstructured":"Juillerat-Jeanneret L (2020) The other angiotensin II receptor: AT2R as a therapeutic target. J Med Chem 63(5):1978\u20131995. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01780","journal-title":"J Med Chem"},{"key":"7072_CR85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0022-510x(02)00256-3","volume":"203","author":"R Kalaria","year":"2002","unstructured":"Kalaria R (2002) Similarities between Alzheimer\u2019s disease and vascular dementia. J Neurol Sci 203:29\u201334. https:\/\/doi.org\/10.1016\/s0022-510x(02)00256-3","journal-title":"J Neurol Sci"},{"issue":"5","key":"7072_CR86","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00401-016-1571-z","volume":"131","author":"RN Kalaria","year":"2016","unstructured":"Kalaria RN (2016) Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer\u2019s disease. Acta Neuropathol 131(5):659\u2013685. https:\/\/doi.org\/10.1007\/s00401-016-1571-z","journal-title":"Acta Neuropathol"},{"issue":"2","key":"7072_CR87","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/08037050310001057","volume":"12","author":"E Kaschina","year":"2003","unstructured":"Kaschina E, Unger T (2003) Angiotensin AT1\/AT2 receptors: regulation, signalling and function. Blood Press 12(2):70\u201388. https:\/\/doi.org\/10.1080\/08037050310001057","journal-title":"Blood Press"},{"issue":"2","key":"7072_CR89","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2174\/1570159x20666220411083922","volume":"21","author":"SS Khan","year":"2023","unstructured":"Khan SS, Khatik GL, Datusalia AK (2023) Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer\u2019s Disease: An Update Cur. Neuropharmacol 21(2):309\u2013339. https:\/\/doi.org\/10.2174\/1570159x20666220411083922","journal-title":"Neuropharmacol"},{"key":"7072_CR90","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2018.01.043","volume":"270","author":"EN Kim","year":"2018","unstructured":"Kim EN, Kim MY, Lim JH, Kim Y, Shin SJ, Park CW, Kim YS, Chang YS, Yoon HE, Choi BS (2018) The protective effect of resveratrol on vascular aging by modulation of the renin\u2013angiotensin system. Atherosclerosis 270:123\u2013131. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.01.043","journal-title":"Atherosclerosis"},{"key":"7072_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2210-8-14","volume":"8","author":"RU Koladiya","year":"2008","unstructured":"Koladiya RU, Jaggi AS, Singh N, Sharma BK (2008) Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats. BMC Pharmacol 8:1\u201312. https:\/\/doi.org\/10.1186\/1471-2210-8-14","journal-title":"BMC Pharmacol"},{"issue":"113409","key":"7072_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2020.113409","volume":"293","author":"MM Koola","year":"2020","unstructured":"Koola MM (2020) Galantamine-Memantine combination in the treatment of Alzheimer\u2019s disease and beyond. Psychiatr Res 293(113409):1\u20138. https:\/\/doi.org\/10.1016\/j.psychres.2020.113409","journal-title":"Psychiatr Res"},{"key":"7072_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-014-0444-x","volume":"16","author":"M Koronyo-Hamaoui","year":"2014","unstructured":"Koronyo-Hamaoui M, Shah K, Koronyo Y, Bernstein E, Giani JF, Janjulia T, Black KL, Shi PD, Gonzalez-Villalobos RA, Fuchs S, Shen XZ (2014) ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer\u2019s disease. Curr Hypertens Rep 16:1\u20139. https:\/\/doi.org\/10.1007\/s11906-014-0444-x","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"7072_CR94","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/1099","volume":"1","author":"LS Krimer","year":"1998","unstructured":"Krimer LS, Muly EC, Williams GV, Goldman-Rakic PS (1998) Dopaminergic regulation of cerebral cortical microcirculation. Nat Neurosci 1(4):286\u2013289. https:\/\/doi.org\/10.1038\/1099","journal-title":"Nat Neurosci"},{"issue":"1\u20132","key":"7072_CR95","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jns.2014.09.021","volume":"347","author":"KJ Kwon","year":"2014","unstructured":"Kwon KJ, Kim MK, Lee EJ, Kim JN, Choi BR, Kim SY, Cho KS, Han JS, Kim HY, Shin CY, Han SH (2014) Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia. J Neurol Sci 347(1\u20132):66\u201377. https:\/\/doi.org\/10.1016\/j.jns.2014.09.021","journal-title":"J Neurol Sci"},{"issue":"129","key":"7072_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2017.00129","volume":"9","author":"JL Labandeira-Garcia","year":"2017","unstructured":"Labandeira-Garcia JL, Rodr\u00edguez-Perez AI, Garrido-Gil P, Rodriguez-Pallares J, Lanciego JL, Guerra MJ (2017) Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration. Front Aging Neurosci 9(129):1\u201316. https:\/\/doi.org\/10.3389\/fnagi.2017.00129","journal-title":"Front Aging Neurosci"},{"key":"7072_CR97","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00702-004-0248-2","volume":"112","author":"G Ladurner","year":"2005","unstructured":"Ladurner G, Kalvach P, Moessler H (2005) Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. J Neural Transm 112:415\u2013428. https:\/\/doi.org\/10.1007\/s00702-004-0248-2","journal-title":"J Neural Transm"},{"key":"7072_CR98","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","volume":"45","author":"JK Liao","year":"2005","unstructured":"Liao JK, Laufs U (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89\u2013118. https:\/\/doi.org\/10.1146\/annurev.pharmtox.45.120403.095748","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"7072_CR99","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0306-4522(00)00365-1","volume":"101","author":"L Librizzi","year":"2000","unstructured":"Librizzi L, Folco G, De Curtis M (2000) Nitric oxide synthase inhibitors unmask acetylcholine-mediated constriction of cerebral vessels in the in vitro isolated guinea-pig brain. Neurosci 101(2):283\u2013287. https:\/\/doi.org\/10.1016\/s0306-4522(00)00365-1","journal-title":"Neurosci"},{"issue":"9","key":"7072_CR100","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3109\/00207454.2012.686543","volume":"122","author":"H Liu","year":"2012","unstructured":"Liu H, Zhang J (2012) Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress. Int J Neurosci 122(9):494\u2013499. https:\/\/doi.org\/10.3109\/00207454.2012.686543","journal-title":"Int J Neurosci"},{"key":"7072_CR101","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S58830","author":"X Liu","year":"2014","unstructured":"Liu X, Zhang J, Sun D, Fan Y, Zhou H, Fu B (2014) Effects of fluoxetine on brain-derived neurotrophic factor serum concentration and cognition in patients with vascular dementia. Clin Interv Aging. https:\/\/doi.org\/10.2147\/CIA.S58830","journal-title":"Clin Interv Aging"},{"issue":"3","key":"7072_CR102","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11418-015-0901-0","volume":"69","author":"H Liu","year":"2015","unstructured":"Liu H, Zhao M, Yang S, Gong DR, Chen DZ, Du DY (2015) (2 R, 3 S)-pinobanksin-3-cinnamate improves cognition and reduces oxidative stress in rats with vascular dementia. J Nat Med 69(3):358\u2013365. https:\/\/doi.org\/10.1007\/s11418-015-0901-0","journal-title":"J Nat Med"},{"key":"7072_CR103","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neulet.2017.04.022","volume":"651","author":"Z Liu","year":"2017","unstructured":"Liu Z, Hu M, Lu P, Wang H, Qi Q, Xu J, Xiao Y, Fan M, Jia Y, Zhang D (2017) Cerebrolysin alleviates cognitive deficits induced by chronic cerebral hypoperfusion by increasing the levels of plasticity-related proteins and decreasing the levels of apoptosis-related proteins in the rat hippocampus. Neurosci Lett 651:72\u201378. https:\/\/doi.org\/10.1016\/j.neulet.2017.04.022","journal-title":"Neurosci Lett"},{"issue":"18","key":"7072_CR104","doi-asserted-by":"publisher","first-page":"10139","DOI":"10.3390\/ijms221810139","volume":"22","author":"R Loera-Valencia","year":"2021","unstructured":"Loera-Valencia R, Eroli F, Garcia-Ptacek S, Maioli S (2021) Brain renin\u2013angiotensin system as novel and potential therapeutic target for Alzheimer\u2019s disease. Int J Mol Sci 22(18):10139","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"7072_CR105","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jns.2012.07.069","volume":"322","author":"F Machicao","year":"2012","unstructured":"Machicao F, Muresanu DF, Hundsberger H, Pfl\u00fcger M, Guekht A (2012) Pleiotropic neuroprotective and metabolic effects of Actovegin\u2019s mode of action. J Neurol Sci 322(1\u20132):222\u2013227. https:\/\/doi.org\/10.1016\/j.jns.2012.07.069","journal-title":"J Neurol Sci"},{"issue":"1","key":"7072_CR106","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/diagnostics13010016","volume":"13","author":"A Martyniak","year":"2022","unstructured":"Martyniak A, Tomasik PJ (2022) A new perspective on the renin-angiotensin system. Diagnostics 13(1):16","journal-title":"Diagnostics"},{"key":"7072_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-815854-8.00031-8","author":"G Marucci","year":"2020","unstructured":"Marucci G, Moruzzi M, Amenta F (2020) Donepezil in the treatment of Alzheimer\u2019s disease. InDiagnosis Manag Dementia. https:\/\/doi.org\/10.1016\/B978-0-12-815854-8.00031-8","journal-title":"InDiagnosis Manag Dementia"},{"key":"7072_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007514.pub3","author":"B McGuinness","year":"2014","unstructured":"McGuinness B, Craig D, Bullock R, Malouf R, Passmore P (2014) Statins for the treatment of dementia. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007514.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"7072_CR109","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000470836","volume":"7","author":"E McKay","year":"2017","unstructured":"McKay E, Counts SE (2017) Multi-infarct dementia: a historical perspective. Dement Geriatr Cogn Disord Extra 7(1):160\u2013171. https:\/\/doi.org\/10.1159\/000470836","journal-title":"Dement Geriatr Cogn Disord Extra"},{"issue":"8","key":"7072_CR110","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/jcmm.12297","volume":"18","author":"S Meilin","year":"2014","unstructured":"Meilin S, Machicao F, Elmlinger M (2014) Treatment with Actovegin improves spatial learning and memory in rats following transient forebrain ischaemia. J Cell Mol Med 18(8):1623\u20131630. https:\/\/doi.org\/10.1111\/jcmm.12297","journal-title":"J Cell Mol Med"},{"issue":"6","key":"7072_CR111","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/gps.652","volume":"17","author":"JS Meyer","year":"2002","unstructured":"Meyer JS, Li Y, Xu G, Thornby J, Chowdhury M, Quach M (2002) Feasibility of treating mild cognitive impairment with cholinesterase inhibitors. Int J Geriatr Psychiatr 17(6):586\u2013588. https:\/\/doi.org\/10.1002\/gps.652","journal-title":"Int J Geriatr Psychiatr"},{"issue":"1","key":"7072_CR112","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G","volume":"54","author":"M Michikawa","year":"1998","unstructured":"Michikawa M, Yanagisawa K (1998) Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis. J Neurosci Res 54(1):58\u201367","journal-title":"J Neurosci Res"},{"key":"7072_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-017-0779-7","volume":"15","author":"MD Mijajlovi\u0107","year":"2017","unstructured":"Mijajlovi\u0107 MD, Pavlovi\u0107 A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, Hermann DM, Assayag EB, Richard E, Thiel A, Kliper E (2017) Post-stroke dementia\u2013a comprehensive review. BMC Med 15:1\u201312. https:\/\/doi.org\/10.1186\/s12916-017-0779-7","journal-title":"BMC Med"},{"issue":"9571","key":"7072_CR114","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/s0140-6736(07)60669-2","volume":"369","author":"S Mochizuki","year":"2007","unstructured":"Mochizuki S, Dahlof B, Shimizu M, Ikewaki K, Yoshikawa M, Taniguchi I, Ohta M, Yamada T, Ogawa K, Kanae K, Kawai M (2007) Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 369(9571):1431\u20131439. https:\/\/doi.org\/10.1016\/s0140-6736(07)60669-2","journal-title":"Lancet"},{"issue":"1","key":"7072_CR115","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1447-0594.2012.00900.x","volume":"13","author":"M Mogi","year":"2013","unstructured":"Mogi M, Horiuchi M (2013) Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases. Ger Gerontol Int 13(1):13\u201318. https:\/\/doi.org\/10.1111\/j.1447-0594.2012.00900.x","journal-title":"Ger Gerontol Int"},{"issue":"1","key":"7072_CR116","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/01.HYP.0000229648.67883.f9","volume":"48","author":"M Mogi","year":"2006","unstructured":"Mogi M, Li JM, Iwanami J, Min LJ, Tsukuda K, Iwai M, Horiuchi M (2006) Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 48(1):141\u2013148. https:\/\/doi.org\/10.1161\/01.HYP.0000229648.67883.f9","journal-title":"Hypertension"},{"issue":"5","key":"7072_CR117","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/153331750301800508","volume":"18","author":"R Moretti","year":"2003","unstructured":"Moretti R, Torre P, Antonello RM, Cazzato G, Bava A (2003) Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients. Am J Alzheimers Dis Other Demen 18(5):265\u2013272. https:\/\/doi.org\/10.1177\/153331750301800508","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"7072_CR118","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2165\/00002512-200421140-00003","volume":"21","author":"R Moretti","year":"2004","unstructured":"Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A (2004) Rivastigmine in frontotemporal dementia: an open-label study. Drugs Aging 21:931\u2013937. https:\/\/doi.org\/10.2165\/00002512-200421140-00003","journal-title":"Drugs Aging"},{"issue":"2","key":"7072_CR119","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1447-0594.2009.00579.x","volume":"10","author":"W Muangpaisan","year":"2010","unstructured":"Muangpaisan W, Brayne C, Alzheimer\u2019s Society Vascular Dementia Systematic Review Group (2010) Systematic review of statins for the prevention of vascular dementia or dementia. Ger Gerontol Int 10(2):199\u2013208. https:\/\/doi.org\/10.1111\/j.1447-0594.2009.00579.x","journal-title":"Ger Gerontol Int"},{"issue":"1","key":"7072_CR120","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/nmt-2020-0052","volume":"11","author":"K Nguyen","year":"2021","unstructured":"Nguyen K, Hoffman H, Chakkamparambil B, Grossberg GT (2021) Evaluation of rivastigmine in Alzheimer\u2019s disease. Neurodegener Dis Manag 11(1):35\u201348. https:\/\/doi.org\/10.2217\/nmt-2020-0052","journal-title":"Neurodegener Dis Manag"},{"issue":"10","key":"7072_CR121","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1161\/01.STR.31.10.2478","volume":"31","author":"Y Nishimura","year":"2000","unstructured":"Nishimura Y, Ito T, Saavedra JM (2000) Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31(10):2478\u20132486. https:\/\/doi.org\/10.1161\/01.STR.31.10.2478","journal-title":"Stroke"},{"issue":"12","key":"7072_CR122","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.3390\/ijms21124268","volume":"21","author":"FY Noureddine","year":"2020","unstructured":"Noureddine FY, Altara R, Fan F, Yabluchanskiy A, Booz GW, Zouein FA (2020) Impact of the renin-angiotensin system on the endothelium in vascular dementia: unresolved issues and future perspectives. Int J Mol Sci 21(12):4268","journal-title":"Int J Mol Sci"},{"issue":"10004","key":"7072_CR123","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/s0140-6736(15)00463-8","volume":"386","author":"JT O'Brien","year":"2015","unstructured":"O\u2019Brien JT, Thomas A (2015) Vascular dementia. Lancet 386(10004):1698\u20131706. https:\/\/doi.org\/10.1016\/s0140-6736(15)00463-8","journal-title":"Lancet"},{"issue":"1","key":"7072_CR124","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","volume":"120","author":"A Oesterle","year":"2017","unstructured":"Oesterle A, Laufs U, Liao JK (2017) Pleiotropic effects of statins on the cardiovascular system. Circ Res 120(1):229\u2013243. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308537","journal-title":"Circ Res"},{"issue":"7","key":"7072_CR125","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1161\/01.STR.0000020094.08790.49","volume":"33","author":"JM Orgogozo","year":"2002","unstructured":"Orgogozo JM, Rigaud AS, St\u00f6ffler A, M\u00f6bius HJ, Forette F (2002) Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke 33(7):1834\u20131839","journal-title":"Stroke"},{"key":"7072_CR126","doi-asserted-by":"publisher","unstructured":"Ota Y, Kanel P, Barr J, Spears CC, Bohnen N (2023) Dopaminergic Nerve Terminal Imaging Across the Spectrum of Aging, Idiopathic Rapid Eye Movement (REM) Sleep Behavior Disorder, Parkinsonism and Dementia. InMolecular Imaging of Neurodegenerative Disorders. Springer 109\u2013125 https:\/\/doi.org\/10.1007\/978-3-031-35098-6_7","DOI":"10.1007\/978-3-031-35098-6_7"},{"key":"7072_CR127","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijcard.2016.04.096","volume":"215","author":"PY Pai","year":"2016","unstructured":"Pai PY, Muo CH, Sung FC, Ho HC, Lee YT (2016) Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes\u2014a real-world population study in Taiwan. Int J Cardiol 215:114\u2013119. https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.096","journal-title":"Int J Cardiol"},{"issue":"1","key":"7072_CR128","first-page":"35","volume":"18","author":"H Panahpour","year":"2010","unstructured":"Panahpour H, Dehghani GA (2010) Inhibition of central angiotensin-converting enzyme with enalapril protects the brain from ischemia\/reperfusion injury in normotensive rat. Daru 18(1):35\u201340","journal-title":"Daru"},{"key":"7072_CR129","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jns.2004.11.017","volume":"229","author":"AP Passmore","year":"2005","unstructured":"Passmore AP, Bayer AJ, Steinhagen-Thiessen E (2005) Cognitive, global, and functional benefits of donepezil in Alzheimer\u2019s disease and vascular dementia: results from large-scale clinical trials. J Neurol Sci 229:141\u2013146. https:\/\/doi.org\/10.1016\/j.jns.2004.11.017","journal-title":"J Neurol Sci"},{"issue":"2","key":"7072_CR130","first-page":"2447","volume":"27","author":"R Pathak","year":"2024","unstructured":"Pathak R, Sharma S, Bhandari M, Nogai L, Mishra R, Saxena A, Reena K, Sharma H (2024) Neuroinflammation at the crossroads of metabolic and neurodegenerative diseases: Causes, consequences and interventions. J Exp Zool India 27(2):2447\u20132461","journal-title":"J Exp Zool India"},{"key":"7072_CR131","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejphar.2014.07.044","volume":"753","author":"AL Pehrson","year":"2014","unstructured":"Pehrson AL, Leiser SC, Gulinello M, Dale E, Li Y, Waller JA, Sanchez C (2014) Treatment of cognitive dysfunction in major depressive disorder\u2014a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin\u2013norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine. Eur J Pharmacol 753:19\u201331. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.044","journal-title":"Eur J Pharmacol"},{"key":"7072_CR132","doi-asserted-by":"publisher","DOI":"10.31031\/GGS.2020.06.000626","author":"G Perrotta","year":"2020","unstructured":"Perrotta G (2020) General overview of \u201chuman dementia diseases\u201d: definitions, classifications, neurobiological profiles and clinical treatments. J Gerontol Ger Stud. https:\/\/doi.org\/10.31031\/GGS.2020.06.000626","journal-title":"J Gerontol Ger Stud"},{"issue":"S1","key":"7072_CR133","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1017\/S1041610203009013","volume":"15","author":"EK Perry","year":"2003","unstructured":"Perry EK (2003) Neurotransmitter abnormalities in vascular dementia. Int Psychogeriatr 15(S1):81\u201387. https:\/\/doi.org\/10.1017\/S1041610203009013","journal-title":"Int Psychogeriatr"},{"issue":"6","key":"7072_CR134","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/joim.12838","volume":"284","author":"B Petek","year":"2018","unstructured":"Petek B, VillaLopez M, Loera Valencia R, Gerenu G, Winblad B, Kramberger MG, Ismail MA, Eriksdotter M, Garcia Ptacek S (2018) Connecting the brain cholesterol and renin\u2013angiotensin systems: potential role of statins and RAS-modifying medications in dementia. J Int Med 284(6):620\u2013642. https:\/\/doi.org\/10.1111\/joim.12838","journal-title":"J Int Med"},{"issue":"2","key":"7072_CR135","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1161\/HYPERTENSIONAHA.122.19859","volume":"38","author":"R Peters","year":"2020","unstructured":"Peters R, Yasar S, Anderson CS, Anstey KJ (2020) Angiotensin receptor blockers and risk of dementia: cohort study in UK primary care practices. J Hypertens 38(2):248\u2013254. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.19859","journal-title":"J Hypertens"},{"key":"7072_CR136","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2165\/00002512-200623030-00006","volume":"23","author":"SG Potkin","year":"2006","unstructured":"Potkin SG, Alva G, Gunay I, Koumaras B, Chen M, Mirski D (2006) A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia. Drugs Aging 23:241\u2013249. https:\/\/doi.org\/10.2165\/00002512-200623030-00006","journal-title":"Drugs Aging"},{"key":"7072_CR137","unstructured":"Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina M (2015)\u00a0World Alzheimer report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends\u00a0(Doctoral dissertation, Alzheimer's disease international) 1\u201388."},{"issue":"5","key":"7072_CR138","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.12669\/pjms.37.5.3854","volume":"37","author":"FX Qi","year":"2021","unstructured":"Qi FX, Hu Y, Li YW, Gao J (2021) Levels of anti-oxidative molecules and inflammatory factors in patients with vascular dementia and their clinical significance. Pak J Med Sci 37(5):1509\u20131513","journal-title":"Pak J Med Sci"},{"issue":"147115","key":"7072_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2020.147115","volume":"1749","author":"SO Rahman","year":"2020","unstructured":"Rahman SO, Hussain S, Alzahrani A, Akhtar M, Najmi AK (2020) Effect of statins on amyloidosis in the rodent models of Alzheimer\u2019s disease: Evidence from the preclinical meta-analysis. Brain Res 1749(147115):1\u201313. https:\/\/doi.org\/10.1016\/j.brainres.2020.147115","journal-title":"Brain Res"},{"key":"7072_CR140","unstructured":"Ramnath U (2022) Physical activity, physical fitness, functional capacity and cognitive performance in older adults: effects of interactive video gaming 1\u2013318. http:\/\/hdl.handle.net\/11427\/37784"},{"key":"7072_CR141","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1006\/nbdi.2001.0422","volume":"5","author":"LM Refolo","year":"2001","unstructured":"Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, Tint GS, Wang R, Mercken M, Petanceska SS, Duff KE (2001) A cholesterol-lowering drug reduces \u03b2-amyloid pathology in a transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Dis 5:890\u2013899. https:\/\/doi.org\/10.1006\/nbdi.2001.0422","journal-title":"Neurobiol Dis"},{"issue":"1","key":"7072_CR142","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1749-6632.2010.05865.x","volume":"1215","author":"T Richard","year":"2011","unstructured":"Richard T, Pawlus AD, Igl\u00e9sias ML, Pedrot E, Waffo-Teguo P, M\u00e9rillon JM, Monti JP (2011) Neuroprotective properties of resveratrol and derivatives. Ann N Y Acad Sci 1215(1):103\u2013108. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05865.x","journal-title":"Ann N Y Acad Sci"},{"key":"7072_CR143","doi-asserted-by":"publisher","first-page":"114319","DOI":"10.1016\/j.expneurol.2023.114319","volume":"362","author":"R Rivas-Santisteban","year":"2023","unstructured":"Rivas-Santisteban R, Lillo J, Ra\u00efch I, Mu\u00f1oz A, Lillo A, Rodr\u00edguez-P\u00e9rez AI, Labandeira-Garc\u00eda JL, Navarro G, Franco R (2023) The cannabinoid CB1 receptor interacts with the angiotensin AT2 receptor. Overexpression of AT2-CB1 receptor heteromers in the striatum of 6-hydroxydopamine hemilesioned rats. Exp Neurol 362:114319","journal-title":"Exp Neurol"},{"issue":"7","key":"7072_CR144","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/jnr.20818","volume":"83","author":"E Rockenstein","year":"2006","unstructured":"Rockenstein E, Torrance M, Mante M, Adame A, Paulino A, Rose JB, Crews L, Moessler H, Masliah E (2006) Cerebrolysin decreases amyloid-\u03b2 production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer\u2019s disease. J Neurosci Res 83(7):1252\u20131261. https:\/\/doi.org\/10.1002\/jnr.20818","journal-title":"J Neurosci Res"},{"issue":"5","key":"7072_CR145","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/jnnp.71.5.589","volume":"71","author":"K Rockwood","year":"2001","unstructured":"Rockwood K, Mintzer J, Truyen L, Wessel T, Wilkinson D (2001) Effects of a flexible galantamine dose in Alzheimer\u2019s disease: a randomised, controlled trial. J Neurol Neurosurg Psychiatr 71(5):589\u2013595. https:\/\/doi.org\/10.1136\/jnnp.71.5.589","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"2","key":"7072_CR146","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/archneur.59.2.223","volume":"59","author":"K Rockwood","year":"2002","unstructured":"Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R, Wolfson C, McDowell I (2002) Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 59(2):223\u2013227. https:\/\/doi.org\/10.1001\/archneur.59.2.223","journal-title":"Arch Neurol"},{"issue":"3","key":"7072_CR147","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/glia.22765","volume":"63","author":"AI Rodriguez-Perez","year":"2015","unstructured":"Rodriguez-Perez AI, Borrajo A, Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL (2015) Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation. Glia 63(3):466\u2013482. https:\/\/doi.org\/10.1002\/glia.22765","journal-title":"Glia"},{"key":"7072_CR148","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0022-510X(02)00252-6","volume":"203","author":"GC Rom\u00e1n","year":"2002","unstructured":"Rom\u00e1n GC (2002) Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 203:7\u201310. https:\/\/doi.org\/10.1016\/S0022-510X(02)00252-6","journal-title":"J Neurol Sci"},{"issue":"1","key":"7072_CR149","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11920-005-0019-2","volume":"7","author":"GC Rom\u00e1n","year":"2005","unstructured":"Rom\u00e1n GC (2005) Cholinergic dysfunction in vascular dementia. Curr Psychiatr Rep 7(1):18\u201326. https:\/\/doi.org\/10.1007\/s11920-005-0019-2","journal-title":"Curr Psychiatr Rep"},{"issue":"4","key":"7072_CR150","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1176\/jnp.2009.21.4.445","volume":"21","author":"DR Royall","year":"2009","unstructured":"Royall DR, Cordes JA, Rom\u00e1n G, Velez A, Edwards A, Schillerstrom JS, Polk MJ (2009) Sertraline improves executive function in patients with vascular cognitive impairment. J Neuropsychiatr Clin Neurosci 21(4):445\u2013454. https:\/\/doi.org\/10.1176\/jnp.2009.21.4.445","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"7072_CR151","doi-asserted-by":"publisher","unstructured":"Rycroft SS, Giovannetti T (2017) Alzheimer\u2019s disease and other dementia disorders. Changes in the brain: Impact on daily life 37-63. https:\/\/doi.org\/10.1007\/978-0-387-98188-8_3","DOI":"10.1007\/978-0-387-98188-8_3"},{"issue":"1","key":"7072_CR152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2010.10.001","volume":"36","author":"JM Saavedra","year":"2011","unstructured":"Saavedra JM, S\u00e1nchez-Lemus E, Benicky J (2011) Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology 36(1):1\u201318. https:\/\/doi.org\/10.1016\/j.psyneuen.2010.10.001","journal-title":"Psychoneuroendocrinology"},{"key":"7072_CR153","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0197-4580(00)82798-0","volume":"21","author":"K Sahin","year":"2000","unstructured":"Sahin K, Stoeffler A, Furtuna P, Rosenwald D, Moebius HJ (2000) Dementia severity and the magnitude of cognitive benefit by memantine treatment. A subgroup analysis of two placebo-controlled clinical trials in vascular dementia. Neurobiolog Aging 21:27","journal-title":"Neurobiolog Aging"},{"issue":"2","key":"7072_CR154","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/bph.14459","volume":"176","author":"KM Sanders","year":"2019","unstructured":"Sanders KM, Ward SM (2019) Nitric oxide and its role as a non-adrenergic, non-cholinergic inhibitory neurotransmitter in the gastrointestinal tract. Br J Pharmacol 176(2):212\u2013227. https:\/\/doi.org\/10.1111\/bph.14459","journal-title":"Br J Pharmacol"},{"issue":"105515","key":"7072_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2021.105515","volume":"166","author":"L Scotti","year":"2021","unstructured":"Scotti L, Bassi L, Soranna D, Verde F, Silani V, Torsello A, Parati G, Zambon A (2021) Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: a meta-analysis. Pharmacol Res 166(105515):1\u201312. https:\/\/doi.org\/10.1016\/j.phrs.2021.105515","journal-title":"Pharmacol Res"},{"issue":"6","key":"7072_CR156","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1089\/dna.2020.6186","volume":"40","author":"S Sha","year":"2021","unstructured":"Sha S, Tan J, Miao Y, Zhang Q (2021) The role of autophagy in hypoxia-induced neuroinflammation. DNA Cell Biol 40(6):733\u2013739. https:\/\/doi.org\/10.1089\/dna.2020.6186","journal-title":"DNA Cell Biol"},{"issue":"9 Pt 2","key":"7072_CR157","first-page":"13","volume":"110","author":"NA Shamalov","year":"2010","unstructured":"Shamalov NA, Stakhovskaia LV, Shetova IM, Efremova NM, Anisimov KV (2010) Efficacy and safety of the combined therapy with citicholine and actovegin in the acute period of ischemic stroke. Zhurnal Nevrol Psikhiatr Im S S Korsakova 110(9 Pt 2):13\u201317 (PMID: 21462435)","journal-title":"Zhurnal Nevrol Psikhiatr Im S S Korsakova"},{"issue":"7\u20138","key":"7072_CR158","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1159\/000504056","volume":"105","author":"R Shi","year":"2020","unstructured":"Shi R, Zheng CB, Wang H, Rao Q, Du T, Bai C, Xiao C, Dai Z, Zhang C, Chen C, Li X (2020) Gastrodin alleviates vascular dementia in a 2-VO-vascular dementia rat model by altering amyloid and tau levels. Pharmacology 105(7\u20138):386\u2013396. https:\/\/doi.org\/10.1159\/000504056","journal-title":"Pharmacology"},{"issue":"8","key":"7072_CR159","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/molecules24081583","volume":"24","author":"A Singh","year":"2019","unstructured":"Singh A, Kukreti R, Saso L, Kukreti S (2019) Oxidative stress: a key modulator in neurodegenerative diseases. Molecules 24(8):1583","journal-title":"Molecules"},{"issue":"11","key":"7072_CR160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7759\/cureus.48960","volume":"15","author":"A Singh","year":"2023","unstructured":"Singh A, Anjankar VP, Sapkale B (2023) Obsessive-compulsive disorder (OCD): a comprehensive review of diagnosis, comorbidities, and treatment approaches. Cureus 15(11):1\u20137. https:\/\/doi.org\/10.7759\/cureus.48960","journal-title":"Cureus"},{"issue":"13","key":"7072_CR204","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","volume":"169","author":"KM Sink","year":"2009","unstructured":"Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Goff DC Jr (2009) Angiotensin-converting enzyme inhibitors and\ncognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med 169(13):1195\u20131202. https:\/\/doi.org\/10.1001\/archinternmed.2009.175","journal-title":"Arch Intern Med"},{"issue":"2","key":"7072_CR161","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/molecules24020343","volume":"24","author":"E Sohn","year":"2019","unstructured":"Sohn E, Kim YJ, Lim HS, Kim BY, Jeong SJ (2019) Hwangryunhaedok-Tang exerts neuropreventive effect on memory impairment by reducing cholinergic system dysfunction and inflammatory response in a vascular dementia rat model. Molecules 24(2):343","journal-title":"Molecules"},{"issue":"114","key":"7072_CR162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2018.00114","volume":"12","author":"H Solleiro-Villavicencio","year":"2018","unstructured":"Solleiro-Villavicencio H, Rivas-Arancibia S (2018) Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4+ T cells in neurodegenerative diseases. Front Cell Neurosci 12(114):1\u201314. https:\/\/doi.org\/10.3389\/fncel.2018.00114","journal-title":"Front Cell Neurosci"},{"key":"7072_CR163","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11010-016-2808-9","volume":"422","author":"H Su","year":"2016","unstructured":"Su H, Li J, Chen T, Li N, Xiao J, Wang S, Guo X, Yang Y, Bu P (2016) Melatonin attenuates angiotensin II-induced cardiomyocyte hypertrophy through the CyPA\/CD147 signaling pathway. Mol Cell Biochem 422:85\u201395. https:\/\/doi.org\/10.1007\/s11010-016-2808-9","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"7072_CR164","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/cam4.1061","volume":"6","author":"K Takane","year":"2017","unstructured":"Takane K, Akagi K, Fukuyo M, Yagi K, Takayama T, Kaneda A (2017) DNA methylation epigenotype and clinical features of NRAS mutation (+) colorectal cancer. Cancer Med 6(5):1023\u20131035. https:\/\/doi.org\/10.1002\/cam4.1061","journal-title":"Cancer Med"},{"issue":"4","key":"7072_CR165","doi-asserted-by":"publisher","first-page":"e13251","DOI":"10.1111\/bpa.13251","volume":"34","author":"HM Tayler","year":"2024","unstructured":"Tayler HM, Skrobot OA, Baron DH, Kehoe PG, Miners JS (2024) Dysregulation of the renin-angiotensin system in vascular dementia. Brain Pathol 34(4):e13251","journal-title":"Brain Pathol"},{"key":"7072_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-021-00477-4","volume":"16","author":"D Tian","year":"2021","unstructured":"Tian D, Guo Y, Zhang D, Gao Q, Liu G, Lin J, Chang Z, Wang Y, Su R, Han Z (2021) Shenzhi Jiannao formula ameliorates vascular dementia in vivo and in vitro by inhibition glutamate neurotoxicity via promoting clathrin-mediated endocytosis. Chin Med 16:1\u201318. https:\/\/doi.org\/10.1186\/s13020-021-00477-4","journal-title":"Chin Med"},{"issue":"5\u20136","key":"7072_CR167","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000084553","volume":"19","author":"H Tomimoto","year":"2005","unstructured":"Tomimoto H, Ohtani R, Shibata M, Nakamura N, Ihara M (2005) Loss of cholinergic pathways in vascular dementia of the Binswanger type. Dement Geriatr Cogn Disord 19(5\u20136):282\u2013288. https:\/\/doi.org\/10.1159\/000084553","journal-title":"Dement Geriatr Cogn Disord"},{"key":"7072_CR168","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9293553","author":"A Urmila","year":"2021","unstructured":"Urmila A, Rashmi P, Nilam G, Subhash B (2021) Recent advances in the endogenous brain renin angiotensin system and drugs acting on it. J Renin-Angiotensin-Aldosterone Syst. https:\/\/doi.org\/10.1155\/2021\/9293553","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"11_Pt_1","key":"7072_CR169","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/ajh\/6.11.951","volume":"6","author":"E Vacher","year":"1993","unstructured":"Vacher E, Forties P, Domergue V, Richer C, Bruneval P, Giudicelli JF (1993) Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats. Am J Hypertens 6(11_Pt_1):951\u2013959","journal-title":"Am J Hypertens"},{"issue":"2","key":"7072_CR170","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.bbr.2009.12.047","volume":"221","author":"AH Van Beek","year":"2011","unstructured":"Van Beek AH, Claassen JA (2011) The cerebrovascular role of the cholinergic neural system in Alzheimer\u2019s disease. Behav Brain Res 221(2):537\u2013542. https:\/\/doi.org\/10.1016\/j.bbr.2009.12.047","journal-title":"Behav Brain Res"},{"issue":"s4","key":"7072_CR171","doi-asserted-by":"publisher","first-page":"S443","DOI":"10.3233\/jad-141542","volume":"42","author":"MA van Buchem","year":"2014","unstructured":"van Buchem MA, Biessels GJ, Brunner la Rocca HP, de Craen AJ, van der Flier WM, Ikram MA, Kappelle LJ, Koudstaal PJ, Mooijaart SP, Niessen W, van Oostenbrugge R (2014) The heart-brain connection: a multidisciplinary approach targeting a missing link in the pathophysiology of vascular cognitive impairment. J Alzheimers Dis 42(s4):S443-551. https:\/\/doi.org\/10.3233\/jad-141542","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"7072_CR172","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/syn.21718","volume":"68","author":"RA V\u00e1zquez-Roque","year":"2014","unstructured":"V\u00e1zquez-Roque RA, Ubhi K, Masliah E, Flores G (2014) Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral hippocampus lesion in the rat. Synapse 68(1):31\u201338. https:\/\/doi.org\/10.1002\/syn.21718","journal-title":"Synapse"},{"key":"7072_CR173","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.expneurol.2015.05.006","volume":"272","author":"P Venkat","year":"2015","unstructured":"Venkat P, Chopp M, Chen J (2015) Models and mechanisms of vascular dementia. Exp Neurol 272:97\u2013108. https:\/\/doi.org\/10.1016\/j.expneurol.2015.05.006","journal-title":"Exp Neurol"},{"issue":"2","key":"7072_CR174","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3233\/JAD-160527","volume":"54","author":"M Vijayan","year":"2016","unstructured":"Vijayan M, Reddy PH (2016) Stroke, vascular dementia, and Alzheimer\u2019s disease: molecular links. J Alzheimers Dis 54(2):427\u2013443. https:\/\/doi.org\/10.3233\/JAD-160527","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"7072_CR175","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tjog.2012.09.005","volume":"51","author":"OB Villaflores","year":"2012","unstructured":"Villaflores OB, Chen YJ, Chen CP, Yeh JM, Wu TY (2012) Curcuminoids and resveratrol as anti-Alzheimer agents. Taiwan J Obstet Gynecol 51(4):515\u2013525. https:\/\/doi.org\/10.1016\/j.tjog.2012.09.005","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"4","key":"7072_CR176","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","volume":"40","author":"A Virdis","year":"2002","unstructured":"Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin EL (2002) Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 40(4):504\u2013510. https:\/\/doi.org\/10.1161\/01.HYP.0000034738.79310.06","journal-title":"Hypertension"},{"issue":"7","key":"7072_CR177","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/00004872-199507000-00007","volume":"13","author":"T Vraamark","year":"1995","unstructured":"Vraamark T, Waldemar G, Strandgaard S, Paulson OB (1995) Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation. J Hypertens 13(7):755\u2013762","journal-title":"J Hypertens"},{"issue":"11","key":"7072_CR178","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1172\/JCI31547","volume":"117","author":"J Wang","year":"2007","unstructured":"Wang J, Ho L, Chen L, Zhao Z, Zhao W, Qian X, Humala N, Seror I, Bartholomew S, Rosendorff C, Pasinetti GM (2007) Valsartan lowers brain \u03b2-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 117(11):3393\u20133402. https:\/\/doi.org\/10.1172\/JCI31547","journal-title":"J Clin Invest"},{"issue":"1","key":"7072_CR179","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/nep3.32","volume":"2","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang Y, Tian N, Ya D, Yang J, Jiang Y, Li X, Lin X, Yang B, Li Q, Liao R (2024) Mechanisms of glutamate metabolic function and dysfunction in vascular dementia. Neuroprotection 2(1):33\u201348. https:\/\/doi.org\/10.1002\/nep3.32","journal-title":"Neuroprotection"},{"issue":"9","key":"7072_CR180","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/jgs.13627","volume":"63","author":"W Wharton","year":"2015","unstructured":"Wharton W, Goldstein FC, Zhao L, Steenland K, Levey AI, Hajjar I (2015) Modulation of Renin-Angiotensin System May Slow Conversion From Mild Cognitive Impairment to Alzheimer\u2019s Disease. J Am Geriatr Soc 63(9):1749\u20131756. https:\/\/doi.org\/10.1111\/jgs.13627","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"7072_CR181","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/jcbfm.2013.159","volume":"33","author":"M Wiesmann","year":"2013","unstructured":"Wiesmann M, Kiliaan AJ, Claassen JA (2013) Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab 33(11):1696\u20131706. https:\/\/doi.org\/10.1038\/jcbfm.2013.159","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7274","key":"7072_CR182","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1136\/bmj.321.7274.1445","volume":"321","author":"GK Wilcock","year":"2000","unstructured":"Wilcock GK, Lilienfeld S, Gaens E (2000) Efficacy and safety of galantamine in patients with mild to moderate Alzheimer\u2019s disease: multicentre randomised controlled trial. Br Med J 321(7274):1445","journal-title":"Br Med J"},{"issue":"2","key":"7072_CR184","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0","volume":"14","author":"B Winblad","year":"1999","unstructured":"Winblad B, Poritis N (1999) Memantine in severe dementia: results of the 9M-best study (benefit and efficacy in severly demented patients during treatment with memantine). Int J Geriatr Psychiatry 14(2):135\u2013146","journal-title":"Int J Geriatr Psychiatry"},{"issue":"10","key":"7072_CR185","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1089\/ars.2009.3064","volume":"13","author":"LG Wood","year":"2010","unstructured":"Wood LG, Wark PA, Garg ML (2010) Anti-oxidant and anti-inflammatory effects of resveratrol in airway disease. Antioxid Redox Signal 13(10):1535\u20131548. https:\/\/doi.org\/10.1089\/ars.2009.3064","journal-title":"Antioxid Redox Signal"},{"key":"7072_CR186","unstructured":"World Health Organization (2015) Update of the Mental Health Gap Action Programme. World Health Organization; 2015."},{"issue":"1","key":"7072_CR187","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.pneurobio.2011.07.001","volume":"95","author":"JW Wright","year":"2011","unstructured":"Wright JW, Harding JW (2011) Brain renin-angiotensin\u2014a new look at an old system. Prog Neurobiol 95(1):49\u201367. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.07.001","journal-title":"Prog Neurobiol"},{"issue":"11","key":"7072_CR188","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3109\/08958378.2012.715698","volume":"24","author":"JL Wright","year":"2012","unstructured":"Wright JL, Zhou S, Churg A (2012) Pulmonary hypertension and vascular oxidative damage in cigarette smoke exposed eNOS\u2212\/\u2212 mice and human smokers. Inhal Toxicol 24(11):732\u2013740. https:\/\/doi.org\/10.3109\/08958378.2012.715698","journal-title":"Inhal Toxicol"},{"issue":"1\u20132","key":"7072_CR189","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jns.2013.11.028","volume":"337","author":"S Xing","year":"2014","unstructured":"Xing S, Zhang J, Dang C, Liu G, Zhang Y, Li J, Fan Y, Pei Z, Zeng J (2014) Cerebrolysin reduces amyloid-\u03b2 deposits, apoptosis and autophagy in the thalamus and improves functional recovery after cortical infarction. J Neurol Sci 337(1\u20132):104\u2013111. https:\/\/doi.org\/10.1016\/j.jns.2013.11.028","journal-title":"J Neurol Sci"},{"key":"7072_CR190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2022.101734","volume":"101734","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhao X, Zhu Z, Zhang L (2022) Vascular dementia: A microglia\u2019s perspective. Ageing Res Rev 101734:1\u201313. https:\/\/doi.org\/10.1016\/j.arr.2022.101734","journal-title":"Ageing Res Rev"},{"issue":"10","key":"7072_CR192","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","volume":"81","author":"S Yasar","year":"2013","unstructured":"Yasar S, Xia J, Yao W, Furberg CD, Xue QL, Mercado CI, Fitzpatrick AL, Fried LP, Kawas CH, Sink KM, Williamson JD (2013) Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology 81(10):896\u2013903. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a35228","journal-title":"Neurology"},{"issue":"6","key":"7072_CR193","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/ijcp.12626","volume":"69","author":"R Ye","year":"2015","unstructured":"Ye R, Hu Y, Yao A, Yang Y, Shi Y, Jiang Y, Zhang J (2015) Impact of renin\u2013angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer\u2019s disease: a meta-analysis. Int J Clin Pract 69(6):674\u2013681. https:\/\/doi.org\/10.1111\/ijcp.12626","journal-title":"Int J Clin Pract"},{"issue":"4","key":"7072_CR194","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3171\/2014.11.JNS14271","volume":"122","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Chopp M, Meng Y, Zhang ZG, Doppler E, Winter S, Schallert T, Mahmood A, Xiong Y (2015) Cerebrolysin improves cognitive performance in rats after mild traumatic brain injury. J Neurosurg 122(4):843\u2013855. https:\/\/doi.org\/10.3171\/2014.11.JNS14271","journal-title":"J Neurosurg"},{"issue":"5","key":"7072_CR195","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.3892\/mmr.2019.10723","volume":"20","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Li Y, Wang Y, Wang G, Mao L, Zhang D, Wang J (2019) Effects of resveratrol on learning and memory in rats with vascular dementia. Mol Med Rep 20(5):4587\u20134593. https:\/\/doi.org\/10.3892\/mmr.2019.10723","journal-title":"Mol Med Rep"},{"issue":"7","key":"7072_CR196","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41419-021-03908-0","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhang J, Liu Y, Zhang P, Nie J, Zhao R, Shi Q, Sun H, Jiao D, Chen Y, Zhao X (2021) Mitochondrial STAT5A promotes metabolic remodeling and the Warburg effect by inactivating the pyruvate dehydrogenase complex. Cell Death Dis 12(7):634","journal-title":"Cell Death Dis"},{"key":"7072_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-99618-1.00026-X","author":"DE Zhang","year":"2023","unstructured":"Zhang DE, Sobey CG, De Silva TM (2023) The role of angiotensin peptides in the brain during health and disease. Angiotensin. https:\/\/doi.org\/10.1016\/B978-0-323-99618-1.00026-X","journal-title":"Angiotensin"},{"key":"7072_CR198","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s11064-015-1536-y","volume":"40","author":"HR Zhao","year":"2015","unstructured":"Zhao HR, Jiang T, Tian YY, Gao Q, Li Z, Pan Y, Wu L, Lu J, Zhang YD (2015) Angiotensin II triggers apoptosis via enhancement of NADPH oxidase-dependent oxidative stress in a dopaminergic neuronal cell line. Neurochem Res 40:854\u2013863. https:\/\/doi.org\/10.1007\/s11064-015-1536-y","journal-title":"Neurochem Res"},{"key":"7072_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11916-016-0584-6","volume":"20","author":"S Zhu","year":"2016","unstructured":"Zhu S, Nahas SJ (2016) CADASIL: imaging characteristics and clinical correlation. Curr Pain Headache R 20:1\u20135. https:\/\/doi.org\/10.1007\/s11916-016-0584-6","journal-title":"Curr Pain Headache R"},{"issue":"9","key":"7072_CR200","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.3390\/ijms22094540","volume":"22","author":"HY Zhu","year":"2021","unstructured":"Zhu HY, Hong FF, Yang SL (2021) The roles of nitric oxide synthase\/nitric oxide pathway in the pathology of vascular dementia and related therapeutic approaches. Int J Mol Sci 22(9):4540","journal-title":"Int J Mol Sci"},{"issue":"175874","key":"7072_CR201","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2023.175874","volume":"955","author":"ML Zhu","year":"2023","unstructured":"Zhu ML, Zhang J, Guo LJ, Yue RZ, Li SS, Cui BY, Guo S, Niu QQ, Yu YN, Wang HH, Yang L (2023) Amorphous selenium inhibits oxidative stress injury of neurons in vascular dementia rats by activating NMDAR pathway. Eur J Pharmacol 955(175874):1\u201313. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175874","journal-title":"Eur J Pharmacol"}],"container-title":["Experimental Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-025-07072-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00221-025-07072-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-025-07072-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T08:22:24Z","timestamp":1748247744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00221-025-07072-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":198,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["7072"],"URL":"https:\/\/doi.org\/10.1007\/s00221-025-07072-1","relation":{},"ISSN":["0014-4819","1432-1106"],"issn-type":[{"value":"0014-4819","type":"print"},{"value":"1432-1106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"130"}}